Answer
Vesicare (solifenacin) should be avoided during breastfeeding because human milk excretion data are unavailable, while solifenacin and/or its metabolites were excreted in mouse milk and caused dose-dependent failure to thrive in neonatal mice.
Sources for this answer
- Vesicare 5mg & 10mg film-coated tabletsAstellas Pharma Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 15Document updated
Sources checked